Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Subscribe To Our Newsletter & Stay Updated